OBJECTIVE: To determine the rate of therapeutic management satisfying the institutional protocol for @entity1 with @entity293 ( @entity293 ) in the context of the emergence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. METHODS: A retrospective, single-center, observational study was carried out for 1 year (2010-2011). Data from all @entity1 admitted to the emergency department with a diagnosis of @entity293 were analysed. Adherence to the protocol was evaluated for the initial management and at re-evaluation with the definitive result of the urine culture. Risk factors for nonadherence were analysed. RESULTS: Among the @entity1 , 393 were included. An ESBL Enterobacteriaceae-related @entity293 was identified in 2.2% of urine analyses. The initial therapeutic management satisfied the protocol for 95% of @entity1 and at re-evaluation for 80%. Nonadherence was related to poorly adapted treatment (59%) and an erroneous indication of dual antibiotic therapy (20%). Variables associated with the inadequacy of the initial management were age less than 3  months (adjusted OR [aOR]: 9.3; 95%CI: 3.5-24.8) and at re-evaluation age under 3  months (aOR: 12.8; 95%CI: 5.5-29.9) and an unconfirmed @entity281 in the final urine culture (aOR: 30.8; 14.7-64.3). CONCLUSION: Adherence to the protocol was good but could be increased by a better re-evaluation procedure with the result of the urine culture. ESBL Enterobacteriaceae-related UTIs were still rare enough to influence the efficacy of management.

[Management of urinary tract infections in XXXX : Evaluation of clinical practice].

@entity1 :: ('9606', 'Species') :: ['children'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity293 :: ('MESH:D014552', 'Disease') :: ['urinary tract infection', 'UTI']
@entity1 :: (9606,Species) :: ['children']
